CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-18 | Thompson Tommy G Director | Sale | −910 | $500.59 | $456K | 8,480 |
| 2025-12-18 | Thompson Tommy G Director | Option exercise · Stock Option | −910 | 4,000 | ||
| 2025-12-18 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-12-18 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,000 | $507.24 | $1.0M | 2,130 |
| 2025-12-18 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −500 | $509.42 | $255K | 1,630 |
| 2025-12-18 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,500 | $510.86 | $766K | 130 |
| 2025-12-18 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −4,000 | 2,000 | ||
| 2025-12-17 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-12-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,500 | $500.52 | $751K | 2,630 |
| 2025-12-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,500 | $501.35 | $1.3M | 130 |
| 2025-12-17 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −4,000 | 6,000 | ||
| 2025-12-16 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-12-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,500 | $492.49 | $1.2M | 1,630 |
| 2025-12-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,000 | $494.00 | $494K | 630 |
| 2025-12-16 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −500 | $497.17 | $249K | 130 |
| 2025-12-16 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −4,000 | 10,000 | ||
| 2025-12-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Option exercise 10b5-1 | +14,625 | $117.76 | $1.7M | 14,625 |
| 2025-12-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −260 | $491.18 | $128K | 14,365 |
| 2025-12-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −1,466 | $492.31 | $722K | 12,899 |
| 2025-12-15 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −2,596 | $493.25 | $1.3M | 10,303 |
Page 167 of 171 · 3,408 trades